CompoAtlas

Huile essentielle Camomille noble

Food supplement declared in France, declaration No 2017-1-294, decision dated 12 January 2017

Huile essentielle Camomille noble, from Therascience Belgium S.A, is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Chamaemelum nobile 210 mg per day. None of the rules we check flags an issue with its declared composition.

Brand
not provided
Food business operator placing the product on the market
Therascience Belgium S.A
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Bottle
Daily dose
2 gouttes, 3 fois par jour
Directions for use
sur un support neutre
Not recommended (according to the manufacturer)
Breastfeeding women, Children (under 12), Pregnant women

Declaration 278267, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Chamaemelum nobile (L.) All.Huile essentielleDistillation210 mg

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Photograph the packaging

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Chamaemelum nobile (L.) All.
    Read the warning, when it applies and the studies cited

    Roman Chamomile - Chamaemelum Nobile

    Route of administration: Oral (Wichtl 2004; Bradley 1992)

    Cautions and warnings

    Ask a healthcare practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (Brinker 2010; Mills and Bone 2000; Blumenthal et al. 1998).

    Sources cited by Health Canada (3)
    • Blumenthal M, Busse WR, Goldberg A, Gruenwald J, Hall T, Riggins CW, Rister RS, editors. Herbal Medicine: Complete Commission E Monographs. Boston (MA): Integrative Medicine Communications; 1998.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Mills S, Bone K. Principles and Practice of Phytotherapy. Toronto (ON): Churchill Livingstone; 2000.

    Health Canada monograph dated 27 March 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Huile essentielle Camomille noble: composition and regulation”, https://compoatlas.com/en/supplements/products/278267-huile-essentielle-camomille-noble, updated 15 November 2026.

List recorded in 2017. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line